The National Epirubican Adjuvant Trial (NEAT) and Scottish Cancer Trials Breast Group (SCTBG) BR9601 randomized phase III adjuvant early breast cancer trials; the updated definitive joint analysis. 43rd Annual American Society of Clinical Oncology Meeting, Chicago, Illinois

HM Earl, L Hiller, JA Dunn, Sarah Bathers, RJ Grieve, David Spooner, RK Agrawal, L Foster, C Twelves, Christopher J. Poole

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)11S
JournalJournal of Clinical Oncology 2007
Issue number185
Publication statusPublished - 1 Jan 2007

Cite this